<DOC>
	<DOCNO>NCT02556073</DOCNO>
	<brief_summary>Poor adherence asthma controller medication may link poor asthma outcome . A metered dose device built-in dose counter help physician monitor drug compliance asthma patient . Mobile-phone base self management open window good asthma control . The present study aim investigate relationship adherence controller medication combine inhale corticosteroid/long act beta2-agonists , assess integrate dose counter , level airway inflammation asthma control . Moreover , investigator also use new asthma self-management Apps enhance drug compliance . With application new , easily available tool , investigator expect increase adherence rate , hence , reduce airway inflammation improve level asthma control .</brief_summary>
	<brief_title>ICS/LABA Combination With Integrated Dose Counter Smartphone APP Improve Asthma Control</brief_title>
	<detailed_description>The study conduct prospective , observational , open label , randomize trial single center ( Taipei Veterans General Hospital ) . After screen , enrol patient randomize either routine care Smartphone self management group . In routine care group , patient treat routine practice real-world set . No additional intervention do . In Smartphone self management group , asthma self management Apps ( My asthma App , GlaxoSmithKline , Chinese version , Line ) , provide multiple function , include health information ( real-time weather condition , air pollution index ) point-of-living , personalize health assessment ( asthma control test , peak flow rate ) interactive action plan ( green , yellow , red light ) , regular remind controller administration , download participant 's Smartphone . The participant educate operate Apps improve asthma control . Participants group use identical controller ( Sal/flu 2 inhalation twice daily plus as-needed rescue ventolin ) schedule follow 24 week .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>1 . Symptomatic asthmatic free controller medication least 3 month 2 . Aged 20 70 year 3 . Lifelong smoke index &lt; 10 packyears 1 . COPD , clinically overt bronchiectasis , lung cancer , active tuberculosis , know specific pulmonary disease . 2 . A chest Xray indicate diagnosis asthma might interfere study . 3 . Major disease abnormality uncontrolled therapy . 4 . Alcohol medication abuse . 5 . Patients low respiratory tract infection receive systemic steroid 4 week prior commencement study . 6 . Unable unwilling comply protocol 7 . Unable use Smartphone</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>asthma control</keyword>
	<keyword>adherence</keyword>
	<keyword>asthma self management plan</keyword>
	<keyword>airway inflammation</keyword>
</DOC>